MUC16 and ovarian cancer: Expectedly, MUC16 was determined to be a frequent driver fusion transcript in the ovarian cancer study by Engqvist and colleagues (Engqvist et al. 2018) and was similarly prevalent in 3/9 (33%) of HGSOC patients in our cohort.